DK108674C - Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf. - Google Patents

Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.

Info

Publication number
DK108674C
DK108674C DK416963A DK416963A DK108674C DK 108674 C DK108674 C DK 108674C DK 416963 A DK416963 A DK 416963A DK 416963 A DK416963 A DK 416963A DK 108674 C DK108674 C DK 108674C
Authority
DK
Denmark
Prior art keywords
preparation
quaternary ammonium
acid addition
addition salts
ammonium compounds
Prior art date
Application number
DK416963A
Other languages
Danish (da)
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK108674C publication Critical patent/DK108674C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK416963A 1963-04-04 1963-09-03 Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf. DK108674C (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27053463A 1963-04-04 1963-04-04
US27053763A 1963-04-04 1963-04-04
US27053663A 1963-04-04 1963-04-04

Publications (1)

Publication Number Publication Date
DK108674C true DK108674C (da) 1968-01-29

Family

ID=27402296

Family Applications (2)

Application Number Title Priority Date Filing Date
DK330264A DK108576C (da) 1963-04-04 1963-09-03 Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK416963A DK108674C (da) 1963-04-04 1963-09-03 Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK330264A DK108576C (da) 1963-04-04 1963-09-03 Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.

Country Status (6)

Country Link
AT (2) AT258920B (de)
DE (1) DE1445457A1 (de)
DK (2) DK108576C (de)
ES (1) ES291187A1 (de)
FR (2) FR1528557A (de)
GB (1) GB1067817A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452798A (en) * 1982-06-22 1984-06-05 Warner-Lambert Company 1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents
GB8619472D0 (en) * 1986-08-09 1986-09-17 Pfizer Ltd Anti-arrhythmia agents
GB9826412D0 (en) * 1998-12-03 1999-01-27 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
AT258920B (de) 1967-12-27
FR94701E (fr) 1969-10-24
FR1528557A (fr) 1968-06-14
DE1445457A1 (de) 1969-01-02
DK108576C (da) 1968-01-08
GB1067817A (en) 1967-05-03
AT258911B (de) 1967-12-27
ES291187A1 (es) 1964-01-16

Similar Documents

Publication Publication Date Title
DK124402B (da) Fremgangsmåde til fremstilling af heterocycliske benzamidoforbindelser eller kvaternære ammoniumsalte eller syreadditionssalte deraf.
DK108972C (da) Fremgangsmåde til fremstilling af lipoylpyridoxamin eller syreadditionssalte deraf.
DK108169C (da) Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxasol eller syreadditionssalte deraf.
DK121083B (da) Fremgangsmåde til fremstilling af benzoxazocinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK116000B (da) Fremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.
DK117354B (da) Fremgangsmåde til fremstilling af disubstituerede aminoethoxyphenylaminer eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK107483C (da) Fremgangsmåde til fremstilling af derivater af 5,6-dihydromorphantridin eller syreadditonssalte eller kvaternære ammoniumforbindelser deraf.
DK112450B (da) Fremgangsmåde til fremstilling af substituerede phthalaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK106335C (da) Fremgangsmåde til fremstilling af derivater af 16-hydroxymethylenyohimbanforbindelser eller syreadditionssalte deraf.
DK111324B (da) Fremgangsmåde til fremstilling af piperidincarboxylsyreestere eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK108576C (da) Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK114977B (da) Fremgangsmåde til fremstilling af substituerede quinoliziner eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK103669C (da) Fremgangsmåde til fremstilling af phenthiazinderivater eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK108394C (da) Fremgangsmåde til fremstilling af substituerede imidazo- eller pyrimido-quinazoliner eller syreadditionssalte deraf.
DK108973C (da) Fremgangsmåde til fremstilling af kinolinforbindelser eller syreadditionssaltene deraf.
DK113077B (da) Fremgangsmåde til fremstilling af basiske ethano-anthracenderivater eller syreadditionssalte deraf.
DK121604B (da) Fremgangsmåde til fremstilling af substituerede iminocycloheptatrienderivater eller syreadditionssalte heraf.
DK107030C (da) Fremgangsmåde til fremstilling af substituerede 1,4-benzodiazepiner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK117899B (da) Fremgangsmåde til fremstilling af phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK110055C (da) Fremgangsmåde til fremstilling af substituerede fulvenyl-methanoler eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK107291C (da) Fremgangsmåde til fremstilling af piperidinderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK111893B (da) Fremgangsmåde til fremstilling af substituerede methylhydraziner eller syreadditionssalte deraf.
DK105649C (da) Fremgangsmåde til fremstilling af 2-dimethylaminopyrazin eller syreadditionssalte deraf.
DK119312B (da) Fremgangsmåde til fremstilling af 2-amino-4-alkoxy-s-trieziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK100302C (da) Fremgangsmåde til fremstilling af basisk substituerede dibenzodiazepinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.